These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33596429)

  • 1. Kmt2c mutations enhance HSC self-renewal capacity and convey a selective advantage after chemotherapy.
    Chen R; Okeyo-Owuor T; Patel RM; Casey EB; Cluster AS; Yang W; Magee JA
    Cell Rep; 2021 Feb; 34(7):108751. PubMed ID: 33596429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kmt2c restricts G-CSF-driven HSC mobilization and granulocyte production in a methyltransferase-independent manner.
    Wang HC; Chen R; Yang W; Li Y; Muthukumar R; Patel RM; Casey EB; Denby E; Magee JA
    Cell Rep; 2024 Aug; 43(8):114542. PubMed ID: 39046877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells.
    Zhang Y; Yan X; Sashida G; Zhao X; Rao Y; Goyama S; Whitman SP; Zorko N; Bernot K; Conway RM; Witte D; Wang QF; Tenen DG; Xiao Z; Marcucci G; Mulloy JC; Grimes HL; Caligiuri MA; Huang G
    Blood; 2012 Aug; 120(5):1118-29. PubMed ID: 22740449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells.
    Jones M; Chase J; Brinkmeier M; Xu J; Weinberg DN; Schira J; Friedman A; Malek S; Grembecka J; Cierpicki T; Dou Y; Camper SA; Maillard I
    J Clin Invest; 2015 May; 125(5):2007-20. PubMed ID: 25866973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hoxb5 defines the heterogeneity of self-renewal capacity in the hematopoietic stem cell compartment.
    Sakamaki T; Kao KS; Nishi K; Chen JY; Sadaoka K; Fujii M; Takaori-Kondo A; Weissman IL; Miyanishi M
    Biochem Biophys Res Commun; 2021 Feb; 539():34-41. PubMed ID: 33418191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML.
    Heidel FH; Bullinger L; Arreba-Tutusaus P; Wang Z; Gaebel J; Hirt C; Niederwieser D; Lane SW; Döhner K; Vasioukhin V; Fischer T; Armstrong SA
    J Exp Med; 2013 Jan; 210(1):15-22. PubMed ID: 23277453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
    Yokoyama A
    Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.
    Zhang YL; Sun JW; Xie YY; Zhou Y; Liu P; Song JC; Xu CH; Wang L; Liu D; Xu AN; Chen Z; Chen SJ; Sun XJ; Huang QH
    Cell Res; 2018 Apr; 28(4):476-490. PubMed ID: 29531312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells.
    Garrison BS; Rybak AP; Beerman I; Heesters B; Mercier FE; Scadden DT; Bryder D; Baron R; Rossi DJ
    Blood; 2017 Aug; 130(5):619-624. PubMed ID: 28615219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
    Wong TN; Ramsingh G; Young AL; Miller CA; Touma W; Welch JS; Lamprecht TL; Shen D; Hundal J; Fulton RS; Heath S; Baty JD; Klco JM; Ding L; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Graubert TA; Ley TJ; Druley T; Link DC; Wilson RK
    Nature; 2015 Feb; 518(7540):552-555. PubMed ID: 25487151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
    Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
    Chen Y; Ernst P
    Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of MLL5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation.
    Heuser M; Yap DB; Leung M; de Algara TR; Tafech A; McKinney S; Dixon J; Thresher R; Colledge B; Carlton M; Humphries RK; Aparicio SA
    Blood; 2009 Feb; 113(7):1432-43. PubMed ID: 18854576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWIST1 preserves hematopoietic stem cell function via the CACNA1B/Ca2+/mitochondria axis.
    Wang N; Yin J; You N; Yang S; Guo D; Zhao Y; Ru Y; Liu X; Cheng H; Ren Q; Cheng T; Ma X
    Blood; 2021 May; 137(21):2907-2919. PubMed ID: 33619534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dpy30 is critical for maintaining the identity and function of adult hematopoietic stem cells.
    Yang Z; Shah K; Khodadadi-Jamayran A; Jiang H
    J Exp Med; 2016 Oct; 213(11):2349-2364. PubMed ID: 27647347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo.
    Jeong M; Park HJ; Celik H; Ostrander EL; Reyes JM; Guzman A; Rodriguez B; Lei Y; Lee Y; Ding L; Guryanova OA; Li W; Goodell MA; Challen GA
    Cell Rep; 2018 Apr; 23(1):1-10. PubMed ID: 29617651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor of activated T-cells, NFATC1, governs FLT3
    Solovey M; Wang Y; Michel C; Metzeler KH; Herold T; Göthert JR; Ellenrieder V; Hessmann E; Gattenlöhner S; Neubauer A; Pavlinic D; Benes V; Rupp O; Burchert A
    J Hematol Oncol; 2019 Jul; 12(1):72. PubMed ID: 31286998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
    Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methyltransferase G9a regulates HoxA9-dependent transcription in AML.
    Lehnertz B; Pabst C; Su L; Miller M; Liu F; Yi L; Zhang R; Krosl J; Yung E; Kirschner J; Rosten P; Underhill TM; Jin J; Hébert J; Sauvageau G; Humphries RK; Rossi FM
    Genes Dev; 2014 Feb; 28(4):317-27. PubMed ID: 24532712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of hematopoietic stem cells from stress-induced exhaustion and aging.
    Singh S; Jakubison B; Keller JR
    Curr Opin Hematol; 2020 Jul; 27(4):225-231. PubMed ID: 32398455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.